Q32 Bio (QTTB) Amortizatization of Intangibles (2018 - 2024)
Q32 Bio's (QTTB) quarterly Amortizatization of Intangibles came in at $15000.0 in Q3 2024, up 101.65% quarter-over-quarter from -$909000.0 in Q2 2023.
Q32 Bio (QTTB) Amortizatization of Intangibles (2018 - 2024) Analysis & Trends
Q32 Bio's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $15000.0 for Q3 2024.
- On a quarterly basis, Amortizatization of Intangibles changed N/A year-over-year to $15000.0 in Q3 2024; TTM through Dec 2025 was $15000.0, a 0.0% change from a year earlier, with the FY2024 full-year figure at $221000.0, changed N/A from the prior year.
- Amortizatization of Intangibles climbed to $15000.0 in Q3 2024 per QTTB's latest filing, from -$909000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.6 million in Q4 2021 and bottomed at -$909000.0 in Q2 2023.
- The 5-year median for Amortizatization of Intangibles is $15000.0 (2024), against an average of $203600.0.
- Biggest YoY gain for Amortizatization of Intangibles was 155700.0% in 2021; the steepest drop was 6350.0% in 2021.
- Year by year, Amortizatization of Intangibles stood at $1000.0 in 2020, then jumped by 155700.0% to $1.6 million in 2021, then tumbled by 31.0% to $1.1 million in 2022, then slumped by 184.56% to -$909000.0 in 2023, then soared by 101.65% to $15000.0 in 2024.
- Per Business Quant, the three latest QTTB Amortizatization of Intangibles figures stand at $15000.0 (Q3 2024), -$909000.0 (Q2 2023), and $909000.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2023 | -909,000.00 |
| Jun 30, 2023 | -909,000.00 |
| Mar 31, 2023 | 909,000.00 |
| Mar 31, 2023 | 909,000.00 |
| Dec 31, 2022 | 1.08 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 781,000.00 |
| Sep 30, 2022 | 781,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | -38,000.00 |
| Mar 31, 2022 | -38,000.00 |
| Dec 31, 2021 | 1.56 Mn |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | -250,000.00 |
| Sep 30, 2021 | -250,000.00 |
| Jun 30, 2021 | -252,000.00 |
| Jun 30, 2021 | -252,000.00 |